Genflow Biosciences plc (GENF.L) LSE
2.10
-0.07499995(-3.45%)
Currency In GBp
- General
- Statistics
- Historical Data
- Profile
- Financials
Genflow Biosciences plc
Address
15 Ingestre Place
London, W1F 0DU
United Kingdom of Great Britain and Northern Ireland (the)
Phone
44 32 4774 95881
Website
Sector
Healthcare
Industry
Biotechnology
Employees
5
First IPO Date
January 17, 2022
Key Executives
| Name | Title | Pay | Year Born |
| Eric Jean Leire | Founder, Chief Executive Officer & Executive Director | 215,793 | 1958 |
| Cedric Szpirer | Head of CMC | 0 | N/A |
Description
Genflow Biosciences plc operates as a biotechnology company that focuses on developing biological interventions aimed at tackling the effects of ageing, slowing or halting the ageing process, and reducing the incidence of age-related diseases with increase in health span. Its lead compound is GF-1002, a suspension of an adeno-associated viral vector-based gene therapy for intravenous infusion. The company is also developing GF-3001, a topical delivery of SIRT6 to the skin; and GF-4001, a non-human pipeline anti-aging for veterinary use. The company was incorporated in 2021 and is headquartered in London, the United Kingdom.
